CSIMarket
 


Johnson and Johnson  (JNJ)
Other Ticker:  
 
 

JNJ's Operating Income Growth by Quarter and Year

Johnson And Johnson's Operating Income results by quarter and year




JNJ Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter January - 4,075.00 4,238.00 4,154.00
III Quarter October - 5,633.00 5,820.00 4,494.00
II Quarter July - 3,990.00 5,353.00 5,464.00
I Quarter April 6,595.00 5,788.00 4,403.00 5,686.00
FY   6,595.00 19,486.00 19,814.00 19,798.00



JNJ Operating Income first quarter 2021 Y/Y Growth Comment
Johnson and Johnson achieved in the first quarter, above Company average Operating Income increase of 13.94% year on year, to $ 6,595.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income growth. While Johnson And Johnson' s Operating Income growth of 13.94% ranks overall at the positon no. 342 in the first quarter.

Explain Operating Income growth


JNJ Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter January - -3.85 % 2.02 % 51.61 %
III Quarter October - -3.21 % 29.51 % -4.57 %
II Quarter July - -25.46 % -2.03 % 0.11 %
I Quarter April 13.94 % 31.46 % -22.56 % 3.42 %
FY   - -1.66 % 0.08 % 7.57 %

Financial Statements
Johnson And Johnson's first quarter 2021 Operating Income $ 6,595.00 millions JNJ's Income Statement
Johnson And Johnson's first quarter 2020 Operating Income $ 5,788.00 millions Quarterly JNJ's Income Statement
New: More JNJ's historic Operating Income Growth >>


JNJ Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter January - -27.66 % -27.18 % -7.57 %
III Quarter October - 41.18 % 8.72 % -17.75 %
II Quarter July - -31.06 % 21.58 % -3.9 %
I Quarter April 61.84 % 36.57 % 5.99 % 107.52 %
FY (Year on Year)   - -1.66 % 0.08 % 7.57 %




Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #20
Overall #342

Operating Income Y/Y Growth Statistics
High Average Low
9.91 % 0.58 % -8.4 %
(March 31, 2008)   (Dec 31 2017)
Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #20
Overall #342
Operating Income Y/Y Growth Statistics
High Average Low
9.91 % 0.58 % -8.4 %
(March 31, 2008)   (Dec 31 2017)

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Johnson And Johnson's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
107.52 % 4.72 % -100 %
(Apr 01 2018)  


JNJ's I. Quarter Q/Q Operating Income Comment
Johnson and Johnson achieved in the I. Quarter 2021 above company average sequential Operating Income jump of 61.84%, to $ 6,595.00 millions, from $4,075.00 millions in the forth quarter.
JNJ is undergoing a remarkable growth, with claiming better then normal gain, but also accelerating pace, Maria  Brown, Major Pharmaceutical Preparations industry expert located in Dallas mentioned.

Within Major Pharmaceutical Preparations industry Johnson and Johnson achieved highest sequential Operating Income growth. While Johnson And Johnson's Operating Income growth quarter on quarter, overall rank is 77.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #77
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #77
Operating Income Q/Q Growth Statistics
High Average Low
107.52 % 4.72 % -100 %
(Apr 01 2018)  


JNJ's I. Quarter Q/Q Operating Income Comment
Johnson and Johnson achieved in the I. Quarter 2021 above company average sequential Operating Income jump of 61.84%, to $ 6,595.00 millions, from $4,075.00 millions in the forth quarter.
Johnson And Johnson is undergoing a remarkable growth, not just reporting above average gain, but also accelerating rate.

Within Major Pharmaceutical Preparations industry Johnson and Johnson achieved highest sequential Operating Income growth. While Johnson And Johnson's Operating Income growth quarter on quarter, overall rank is 77.


Johnson And Johnson's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Apr 04 2021)
12 Months Ending
(Jan 03 2021)
12 Months Ending
(Sep 27 2020)
12 Months Ending
(Jun 28 2020)
12 Months Ending
(Mar 29 2020)
Cumulative Operating Income 12 Months Ending $ 20,293.00 $ 19,486.00 $ 19,649.00 $ 19,836.00 $ 21,199.00
Y / Y Operating Income Growth (TTM) -4.27 % -1.66 % -0.41 % 7.78 % 14.5 %
Year on Year Operating Income Growth Overall Ranking # 350 # 1136 # 59 # 100 # 632
Seqeuential Operating Income Change (TTM) 4.14 % -0.83 % -0.94 % -6.43 % 6.99 %
Seq. Operating Income Growth (TTM) Overall Ranking # 342 # 1448 # 1261 # 170 # 170




Cumulative Operating Income growth Comment
Johnson And Johnson's cumulative 12 months Operating Income continue to decrease, but on the faster rate at -4.27% year on year, at Apr 04 2021 compare to the -1.66% decrease at Jan 03 2021. If the Johnson And Johnson's fiscal year would end at Apr 04 2021, annual Operating Income would be $20,293 millions.

Within the Healthcare sector 30 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 350, from total ranking in previous quarter at 1136.

Operating Income TTM Q/Q Growth Statistics
High Average Low
9.91 %
0.58 %
-8.4 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 31
Overall # 350

Operating Income TTM Y/Y Growth Statistics
High Average Low
24.17 %
3.1 %
-16.24 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 20
S&P 500 # 342
Cumulative Operating Income growth Comment
Johnson And Johnson's cumulative 12 months Operating Income continue to decrease, but on the faster rate at -4.27% year on year, at Apr 04 2021 compare to the -1.66% decrease at Jan 03 2021. If the Johnson And Johnson's fiscal year would end at Apr 04 2021, annual Operating Income would be $20,293 millions.

Within the Healthcare sector 30 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 350, from total ranking in previous quarter at 1136.

Operating Income TTM Q/Q Growth Statistics
High Average Low
9.91 %
0.58 %
-8.4 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 31
Overall # 350

Operating Income TTM Y/Y Growth Statistics
High Average Low
24.17 %
3.1 %
-16.24 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 20
S&P 500 # 342




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
JNJ's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for JNJ's Competitors
Operating Income Growth for Johnson And Johnson's Suppliers
Operating Income Growth for JNJ's Customers

You may also want to know
JNJ's Annual Growth Rates JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roe JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Comparisons



Companies with similar Operating Income decrease for the quarter ending Apr 04 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Apr 04 2021


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OLBG's Profile

Stock Price

OLBG's Financials

Business Description

Fundamentals

Charts & Quotes

OLBG's News

Suppliers

OLBG's Competitors

Customers & Markets

Economic Indicators

OLBG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071